Canine Mammary Tumours (CMTs) exploit Mitochondrial Cholesterol for aggressive reprogramming
Liana Hardy, Brindha Kannan, Manuel Rigon, Genevieve Benton-Hawthorn, Renato Lopes Previdelli, Iris M. Reichler, Franco Guscetti, Mariusz Pawel Kowalewski, Michelangelo Campanella
This study shows TSPO's role in aggressive canine mammary tumours by facilitating mitochondrial cholesterol handling, enhancing survival, and reducing Tamoxifen efficacy.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · Oct 31, 2024Peer-reviewedCancer Biology